Artivion | CRY - Ebit


Artivion reported $4.79M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 1.36B 775M Sep/2026
Accuray USD 11.38M 12.71M Sep/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
J&J USD 6.47B 1B Sep/2026
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Orthofix International USD 6.12M 1.91M Dec/2025
Pfizer USD -180M 5.16B Jun/2026
ResMed USD 454.34M 51.33M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 4.46M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Terumo JPY 89.48B 58.03B Jun/2026
Trinity Biotech USD -1.3M 8.72M Dec/2025